Authors: Rego, EM Garcia, AB Carneiro, JJ Falcao, RP

Citation: Em. Rego et al., Immunophenotype of normal and leukemic bone marrow B-precursors in a Brazilian population. A comparative analysis by quantitative fluorescence cytometry, BRAZ J MED, 34(2), 2001, pp. 183-194

Authors: Rego, EM Pandolfi, PP

Citation: Em. Rego et Pp. Pandolfi, Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models, SEM HEMATOL, 38(1), 2001, pp. 54-70

Authors: Rego, EM Wang, ZG Peruzzi, D He, LZ Cordon-Cardo, C Pandolfi, PP

Citation: Em. Rego et al., Role of promyelocytic leukemia (PML) protein in tumor suppression, J EXP MED, 193(4), 2001, pp. 521-529

Authors: He, LZ Bhaumik, M Tribioli, C Rego, EM Ivins, S Zelent, A Pandolfi, PP

Citation: Lz. He et al., Two critical hits for promyelocytic leukemia, MOL CELL, 6(5), 2000, pp. 1131-1141

Authors: Rego, EM He, LZ Warrell, RP Wang, ZG Pandolfi, PP

Citation: Em. Rego et al., Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins, P NAS US, 97(18), 2000, pp. 10173-10178

Authors: Rego, EM Tone, LG Garcia, AB Falcao, RP

Citation: Em. Rego et al., CD10 and CD19 fluorescence intensity of B-cell precursors in normal and leukemic bone marrow. Clinical characterization of CD10(+strong) and CD10(+weak) common acute lymphoblastic leukemia, LEUK RES, 23(5), 1999, pp. 441-450